Literature DB >> 18264746

Endothelin system and atrial fibrillation post-cardiac surgery.

Theofilos M Kolettis1, Zenon S Kyriakides, Eleni Zygalaki, Stamatis Kyrzopoulos, Loukas Kaklamanis, Nikolaos Nikolaou, Evi S Lianidou, Dimitrios Th Kremastinos.   

Abstract

OBJECTIVE: We investigated the relation between the endothelin system and atrial fibrillation.
BACKGROUND: Endothelin has been implicated in the pathophysiology of atrial fibrillation, but the exact role of A- and B-receptors is unknown.
METHODS: We obtained right atrial biopsies from patients in sinus rhythm and preserved left ventricular function, undergoing off-pump coronary artery bypass grafting. The expression of endothelin, A- and B-receptors was measured using real time reverse-transcribed polymerase chain reaction.
RESULTS: We studied 52 patients (45 male, mean age 66+/-1 years, mean ejection fraction 52+/-1%). During a 5-day post-operative period, persistent atrial fibrillation occurred in 15 patients (28.8%). Endothelin mRNA expression was comparable in patients who subsequently developed atrial fibrillation and in those maintaining sinus rhythm. However, the former group displayed down-regulation of endothelin A- (by approximately 60%, p=0.0059) and of B-receptors (by approximately 40%, p=0.0084). The decreased endothelin A-receptor expression could predict atrial fibrillation occurrence (Wilks lambda=0.86, F=6.16, p=0.017).
CONCLUSION: Decreased endothelin A- and B-receptor expression is associated with atrial fibrillation after bypass surgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18264746     DOI: 10.1007/s10840-008-9206-5

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  22 in total

1.  Real-time reverse transcription-PCR quantification of vascular endothelial growth factor splice variants.

Authors:  Eleni Zygalaki; Aliki Stathopoulou; Christos Kroupis; Loukas Kaklamanis; Zenon Kyriakides; Dimitrios Kremastinos; Evi S Lianidou
Journal:  Clin Chem       Date:  2005-08       Impact factor: 8.327

2.  Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.

Authors:  S Masson; M Gorini; M Salio; D Lucci; R Latini; A P Maggioni
Journal:  Ital Heart J       Date:  2000-04

3.  Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?

Authors:  I Sharif; K A Kane; C L Wainwright
Journal:  Cardiovasc Res       Date:  1998-09       Impact factor: 10.787

4.  Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; Y Hiroi; T Mizuno; K Maemura; H Kurihara; R Aikawa; H Takano; Y Yazaki
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

5.  Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes.

Authors:  Andrew Proven; H Llewelyn Roderick; Stuart J Conway; Michael J Berridge; Jeffrey K Horton; Stephen J Capper; Martin D Bootman
Journal:  J Cell Sci       Date:  2006-08-01       Impact factor: 5.285

6.  Endothelin-1 and photoreleased diacylglycerol increase L-type Ca2+ current by activation of protein kinase C in rat ventricular myocytes.

Authors:  J Q He; Y Pi; J W Walker; T J Kamp
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

7.  Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic.

Authors:  Calum J Redpath; Andrew C Rankin; Kathleen A Kane; Antony J Workman
Journal:  J Mol Cell Cardiol       Date:  2006-04-17       Impact factor: 5.000

Review 8.  Epidemiology of atrial fibrillation: a current perspective.

Authors:  Lin Y Chen; Win-Kuang Shen
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

Review 9.  Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension.

Authors:  T F Lüscher; Y Dohi; M Tschudi
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

10.  Increased circulating endothelin-1 in rheumatic mitral stenosis: irrelevance to left atrial and pulmonary artery pressures.

Authors:  Mien-Cheng Chen; Chiung-Jen Wu; Hon-Kan Yip; Hsueh-Wen Chang; Chien-Jen Chen; Teng-Hung Yu; Wei Chin Hung
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

View more
  5 in total

1.  Big endothelin-1 as a predictor of atrial fibrillation recurrence after primary ablation only in patients with paroxysmal atrial fibrillation.

Authors:  H Wang; J Liu; P Fang; S Lei; X Li; Y Hou; S Zhang
Journal:  Herz       Date:  2012-06-06       Impact factor: 1.443

2.  Agonist-induced localization of Gq-coupled receptors and G protein-gated inwardly rectifying K+ (GIRK) channels to caveolae determines receptor specificity of phosphatidylinositol 4,5-bisphosphate signaling.

Authors:  Shanyu Cui; Won-Kyung Ho; Seong-Tae Kim; Hana Cho
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model.

Authors:  Fadia Mayyas; Seiichiro Sakurai; Rashmi Ram; Julie H Rennison; Eui-Seock Hwang; Laurie Castel; Beth Lovano; Marie-Luise Brennan; Douglas Bibus; Bill Lands; John Barnard; Mina K Chung; David R Van Wagoner
Journal:  Cardiovasc Res       Date:  2010-11-30       Impact factor: 10.787

4.  Associations of big endothelin-1 and C-reactive protein in atrial fibrillation.

Authors:  Li-Hui Zheng; Wei Sun; Yan Yao; Bing-Bo Hou; Yu Qiao; Shu Zhang
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

5.  Association between big endothelin-1 and CHADS2/CHA2DS2-VASc scores in non-valvular atrial fibrillation.

Authors:  Li-Hui Zheng; Shang-Yu Liu; Feng Hu; Er-Peng Liang; Ling-Min Wu; Hong-Lei Wang; Ammar M Killu; Yan Yao
Journal:  J Geriatr Cardiol       Date:  2019-11       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.